Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner purchased 375,000 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were bought at an average price of A$0.08 ($0.05) per share, with a total value of A$30,000.00 ($19,480.52).
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Further Reading
- Five stocks we like better than Percheron Therapeutics
- Options Trading – Understanding Strike Price
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- How to invest in marijuana stocks in 7 steps
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
